Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK.

about

Replicating Health Economic Models: Firm Foundations or a House of Cards?Microfracture is more cost-effective than autologous chondrocyte implantation: a review of level 1 and level 2 studies with 5 year follow-up.

P2860

Q47329445-BA0D4ECF-1D42-45A6-AF82-3E5048DDE890 Q47612374-D6B92370-6E40-4CDA-958E-FA0F0BF52C9C

P2860

Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK.

Item

http://www.wikidata.org/entity/Q39672666

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cost Effectiveness of Characte ...... Defects of the Knee in the UK.

@en

Cost Effectiveness of Characte ...... Defects of the Knee in the UK.

@nl

type

Item

label

Cost Effectiveness of Characte ...... Defects of the Knee in the UK.

@en

Cost Effectiveness of Characte ...... Defects of the Knee in the UK.

@nl

prefLabel

Cost Effectiveness of Characte ...... Defects of the Knee in the UK.

@en

Cost Effectiveness of Characte ...... Defects of the Knee in the UK.

@nl

P1476

Cost Effectiveness of Characte ...... Defects of the Knee in the UK

@en

P2093

Anthony J Hatswell

http://www.w3.org/2001/XMLSchema#string

Jamie Elvidge

http://www.w3.org/2001/XMLSchema#string

P2860

A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluation.

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.

Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture.

Clinical Outcomes of Characterized Chondrocyte Implantation.

Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?

The NICE cost-effectiveness threshold: what it is and what that means.

The John Insall Award: A minimum 10-year outcome study of autologous chondrocyte implantation.

The cost utility of autologous chondrocytes implantation using ChondroCelect® in symptomatic knee cartilage lesions in Belgium.

Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters.

Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients?

P2888

s40273-016-0423-y

P304

1145-1159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40273-016-0423-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ash Bullement

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27318837

http://www.w3.org/2001/XMLSchema#string

P921

cartilage

Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK.

about

P2860

P2860

Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921